<?xml version="1.0" encoding="UTF-8"?>
<p>According to the estimated free binding energies, all evaluated drugs could act as SARS-CoV-2 protease inhibitors. Among the HCV protease inhibitors, Faldaprevir exhibited the lowest free binding energy.</p>
